We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Insulated Transport System Safeguards Transplant Hearts

By HospiMedica International staff writers
Posted on 23 Jan 2019
Print article
Image: The SherpaPak cardiac transport system (Photo courtesy of Paragonix).
Image: The SherpaPak cardiac transport system (Photo courtesy of Paragonix).
A new organ transport system protects small adult and pediatric donor hearts on their way to transplant recipients.

The Paragonix Technologies (Braintree, MA, USA) SherpaPak cardiac transport system (CTS) is a single-use storage unit designed to standardize donor heart preservation and transport during triage to the recipient patient. To maintain a cold storage temperature range of 4-8°C, SherpaPak combines an insulated double walled rigid storage canister, non-toxic disposable cold packs, and a cradle to immerse and suspend the heart in a cold storage fluid that provides thermal stability at ambient and extreme temperatures.

Features of the system include an inner organ canister with a volume of four liters, a suspension system that provides both physical and thermal protection to the heart, a real-time preservation temperature sensor, and connectors to cover most aorta sizes, allowing transport of both adult and pediatric hearts. A data logger monitors organ temperature during transport, and a Bluetooth connectivity app monitors, records, and downloads preservation temperature and storage times to handheld devices. The intended organ storage time is up to four hours, but thermal stability has been demonstrated for over 12 hours.

“Our effective product implementation plan, combined with a variety of clinical support tools tailored individually to each transplant center, have resulted in sustained clinical utilization of Paragonix SherpaPak cardiac transport system,” said Bill Edelman, chairman and CEO of Paragonix. “We believe that improving the utilization of donated hearts is critical to patients in end-stage heart failure who are desperate for this precious commodity.”

Approximately 3,500 heart transplants are performed every year in the world, more than half of which occur in the United States. Post-operation survival periods average 15 years.

Related Links:
Paragonix Technologies

Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Breast Imaging Workstation
SecurView

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.